These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 36817795)
1. The under investigated facet of the COVID-19 pandemic: Molecular analysis of secondary bacterial infections at a COVID dedicated intensive care unit within a tertiary care center in Lebanon. Sleiman A; Abdelkhalek P; Doumat G; Atallah F; Hamadeh L; Moussa P; Bou Akl I; Dbaibo G; Araj GF; Kanj SS; Mahfouz R; Matar GM; Kanafani ZA; Abou Fayad AG Front Med (Lausanne); 2023; 10():1001476. PubMed ID: 36817795 [TBL] [Abstract][Full Text] [Related]
2. Carbapenem and colistin-resistant bacteria in North Lebanon: Coexistence of mcr-1 and NDM-4 genes in Escherichia coli. Al-Bayssari C; Nawfal Dagher T; El Hamoui S; Fenianos F; Makdissy N; Rolain JM; Nasreddine N J Infect Dev Ctries; 2021 Jul; 15(7):934-342. PubMed ID: 34343118 [TBL] [Abstract][Full Text] [Related]
3. Occurrence of the Colistin Resistance Gene Mikhayel M; Leclercq SO; Sarkis DK; Doublet B Microbiol Spectr; 2021 Oct; 9(2):e0002521. PubMed ID: 34494875 [TBL] [Abstract][Full Text] [Related]
4. Virulence Determinants and Plasmid-Mediated Colistin Resistance Tartor YH; Gharieb RMA; Abd El-Aziz NK; El Damaty HM; Enany S; Khalifa E; Attia ASA; Abdellatif SS; Ramadan H Front Cell Infect Microbiol; 2021; 11():761417. PubMed ID: 34888259 [TBL] [Abstract][Full Text] [Related]
5. [In Vitro Activity of Ceftazidime-avibactam and Colistin Against Carbapenem-Resistant Klebsiella pneumoniae Clinical Isolates]. Hoşbul T; Aydoğan CN; Kaya S; Bedir O; Gümral R; Albay A Mikrobiyol Bul; 2022 Apr; 56(2):218-229. PubMed ID: 35477226 [TBL] [Abstract][Full Text] [Related]
6. [Investigation of Plasmid Mediated mcr Colistin Resistance Gene in Clinical Enterobacterales Isolates]. Özkaya E; Buruk CK; Tosun İ; Toraman B; Kaklıkkaya N; Aydın F Mikrobiyol Bul; 2020 Apr; 54(2):191-202. PubMed ID: 32723275 [TBL] [Abstract][Full Text] [Related]
7. In vitro antimicrobial susceptibility of clinical respiratory isolates to ceftazidime-avibactam and comparators (2016-2018). Piérard D; Stone GG BMC Infect Dis; 2021 Jun; 21(1):600. PubMed ID: 34162341 [TBL] [Abstract][Full Text] [Related]
10. Phenotypic and genotypic characterisation of cephalosporin-, carbapenem- and colistin-resistant Gram-negative bacterial pathogens in Lebanon, Jordan and Iraq. Moghnieh RA; Moussa JA; Aziz MA; Matar GM J Glob Antimicrob Resist; 2021 Dec; 27():175-199. PubMed ID: 34481122 [TBL] [Abstract][Full Text] [Related]
11. Bacterial Epidemiology and Antimicrobial Resistance Profiles in Children Reported by the ISPED Program in China, 2016 to 2020. Fu P; Xu H; Jing C; Deng J; Wang H; Hua C; Chen Y; Chen X; Zhang T; Zhang H; Chen Y; Yang J; Lin A; Wang S; Cao Q; Wang X; Deng H; Cao S; Hao J; Gao W; Huang Y; Yu H; Wang C Microbiol Spectr; 2021 Dec; 9(3):e0028321. PubMed ID: 34730410 [TBL] [Abstract][Full Text] [Related]
12. In vitro activity of ceftazidime-avibactam and comparators against Gram-negative bacterial isolates collected in the Asia-Pacific region as part of the INFORM program (2015-2017). Ko WC; Stone GG Ann Clin Microbiol Antimicrob; 2020 Apr; 19(1):14. PubMed ID: 32238155 [TBL] [Abstract][Full Text] [Related]
14. Prevalence and characterisation of carbapenemase encoding genes in multidrug-resistant Gram-negative bacilli. Haji SH; Aka STH; Ali FA PLoS One; 2021; 16(11):e0259005. PubMed ID: 34723978 [TBL] [Abstract][Full Text] [Related]
15. Antimicrobial susceptibility profiles of gram-negative bacteria causing infections collected across India during 2014-2016: Study for monitoring antimicrobial resistance trend report. Veeraraghavan B; Jesudason MR; Prakasah JAJ; Anandan S; Sahni RD; Pragasam AK; Bakthavatchalam YD; Selvakumar RJ; Dhole TN; Rodrigues C; Roy I; Joshi S; Chaudhuri BN; Chitnis DS Indian J Med Microbiol; 2018; 36(1):32-36. PubMed ID: 29735823 [TBL] [Abstract][Full Text] [Related]
16. Molecular epidemiology and antimicrobial susceptibility of Sewunet T; Asrat D; Woldeamanuel Y; Aseffa A; Giske CG Front Microbiol; 2022; 13():951857. PubMed ID: 36204631 [TBL] [Abstract][Full Text] [Related]
17. Elucidation of molecular mechanism for colistin resistance among Gram-negative isolates from tertiary care hospitals. Urooj M; Ullah R; Ali S; Mohyuddin A; Mirza HM; Faryal R J Infect Chemother; 2022 May; 28(5):602-609. PubMed ID: 35058128 [TBL] [Abstract][Full Text] [Related]
18. Antimicrobial susceptibility testing of clinical isolates of Gram-negative bacilli collected in Morocco by the ATLAS Global Surveillance Program from 2018 to 2020. Karlowsky JA; Bouchillon SK; Benaouda A; Soraa N; Zerouali K; Mohamed N; Alami T; Sahm DF J Glob Antimicrob Resist; 2022 Sep; 30():23-30. PubMed ID: 35447385 [TBL] [Abstract][Full Text] [Related]
19. In vitro Synergistic Activities of Fosfomycin in Combination with Other Antimicrobial Agents Against Carbapenem-Resistant Kaewnirat K; Chuaychob S; Chukamnerd A; Pomwised R; Surachat K; Phoo MTP; Phaothong C; Sakunrang C; Jeenkeawpiam K; Hortiwakul T; Charernmak B; Chusri S Infect Drug Resist; 2022; 15():1777-1791. PubMed ID: 35437346 [TBL] [Abstract][Full Text] [Related]